What is the translation of " PEG INTRON " in Danish?

• pegintron

Examples of using Peg intron in English and their translations into Danish

Peg Intron Cm ax and AUC measurements increase in a dose-related manner.
PegIntron Cmax og AUC målinger stiger på en dosis- relateret måde.

This study showed that Peg Intron was superior to interferon alfa-2b Table 5.
Dette studie viste, at PegIntron var bedre end interferon alfa- 2b Tabel 5.

Renal clearance appears to account for 30% of total clearance of Peg Intron.
Renal udskillelse synes at være ansvarlig for 30% af total clearance af PegIntron.

Discontinuation of Peg Intron should be considered in patients who develop new or worsening ophthalmological disorders.
Seponering af PegIntron bør overvejes hos patienter, som udvikler nye eller forværrede oftalmologiske lidelser.

Neutrophil and white cell count reductions at the end of week 4 correlated with the dose of Peg Intron.
Reduktion af antallet af neutrofile og hvide blodlegemer ved slutningen af uge 4 svarede til dosis af PegIntron.

Hold the Peg Intron pre-filled pen with your fingers wrapped around the pen body barrel and your thumb on the dosing button figure 7.
Hold PegIntron fyldt pen med Deres fingre rundt om selve pennen og Deres tommelfinger på doseringsknappen figur 7.

Both the Metavir score and Ishak grade decreased among subjects treated with Peg Intron in combination with ribavirin.
Både Metavir score og Ishak graden faldt blandt forsøgspersoner, der blev behandlet med PegIntron i kombination med ribavirin.

Combination treatment Peg Intron, when given with ribavirin capsules, is usually given at a dose of 1.5 microgram/kg once a week.
PegIntron, når det anvendes med ribavirin kapsler, gives sædvanligvis i en dosis på 1, 5 mikrogram/ kg en gang om ugen.

These adverse reactions were common(≥1/100 to< 1/10) in clinical trials in patients treated with Peg Intron monother apy.
Bivirkninger var almindelige(≥ 1/ 100 til< 1/ 10) i kliniske undersøgelser hos patienter behandlet med PegIntron monoterapi.

Your doctor has prescribed Peg Intron specifically for you and your current condition; do not share this medicine with anyone else.
Deres læge har ordineret PegIntron specielt til Dem og Deres nuværende tilstand; del ikke denne medicin med nogen andre.

Dental and gum disorders, which may lead to loss of teeth, have been reported in patients receiving Peg Intron and ribavirin combination therapy.
Tand- og tandkødslidelser, som kan lede til tab af tænder, er blevet rapporteret hos patienter, der fik PegIntron og ribavirin kombinationsbehandling.

Mean(SD) Peg Intron elimin ation half-life is approximately 40 hours(13.3 hours), with apparent clearance of 22.0 ml/hr·kg.
Gennemsnitlig(standard deviation) PegIntron eliminationshalveringstid er cirka 40 timer(13, 3 timer) med påviselig clearance på 22, 0 ml/ time· kg.

There were some cases of more severe neutropenia in patients treated with the recommended doses of Peg Intron in combin ation with ribavirin WHO grade 3.
Der var nogle tilfælde af mere alvorlig neutropeni hos patienter behandlet med de anbefalede doser af PegIntron i kombination med ribavirin WHO grad 3.

Following single doses of Peg Intron between 0.25 and 2.0 micrograms/kg/week, serum neopterin concentration was increased in a dose- related manner.
Efter enkeltdoser af PegIntron mellem 0, 25 og 2, 0 mikrogram/ kg/ uge, blev serum neopterin koncentrationen øget på en dosisafhængig måde.

These findings may partly relate to improved metabolic capacity due to reduced hepatic inflammation in patients undergoing treatment with Peg Intron.
Disse fund kan delvist være relaterede til forbedret metabolisk kapacitet, som følge af reduceret hepatisk inflammation hos patienter i behandling med PegIntron.

The use of Peg Intron in combination with ribavirin had no observable negative impact on the control of HIV viraemia during therapy or follow-up.
Anvendelsen af PegIntron i kombination med ribavirin havde ingen observerbar negativ indvirkning på kontrollen af HIV- viræmi under behandling eller opfølgning.

However, response rates in this trial were shown to be dependent also on the dose of ribavirin administered in combination with Peg Intron or interferon alfa-2b.
Responsraterne i denne undersøgelse blev imidlertid vist også at være afhængige af dosen af ribavirin indgivet i kombination med PegIntron eller interferon alfa- 2b.

Treatment with Peg Intron in combination with ribavirin was associated with decreases in absolute CD4+ cell counts within the first 4 weeks without a reduction in CD4+ cell percentage.
Behandling med PegIntron i kombination med ribavirin, blev associeret med et fald i absolut CD4+- celletælling inden for de 4 første uger uden en reduktion i CD4+- celleprocenten.

Haematological abnormalities were more frequently reported in patients receiving Peg Intron in combination with ribavirin when compared to patients receiving interferon alfa-2b in combination with ribavirin.
Hæmatologiske anomaliteter blev rapporteret mere hyppigt hos patienter, der modtog PegIntron i kombination med ribavirin end hos patienter, der modtog interferon alfa- 2b i kombination med ribavirin.

Peg Intron clinical trials- Naïve patients Two pivotal trials have been conducted, one(C/I97-010) with PegIntron monotherapy; the other(C/I98-580) with PegIntron in combination with ribavirin.
PegIntron kliniske undersøgelser- Naive patienter To pivotale undersøgelser er blevet udført, en(C/ I97- 010) med PegIntron monoterapi; den anden(C/ I98- 580) med PegIntron i kombination med ribavirin.

Results from a multiple-dose probe study assessing P450 substrates in chronic hepatitis C patients receiving once weekly Peg Intron(1.5 µg/kg) for 4 weeks demonstrated an increase in activity of.
Resultater fra en multidosis undersøgelse, som vurderede P450 substrater hos kroniske hepatitis C patienter, som modtog PegIntron(1, 5 µg/ kg) en gang ugentligt i 4 uger, viste en øgning i aktiviteten af CYP2D6 og CYP2C8/ 9.

Caution is therefore advised when Peg Intron treatment is initiated for chronic hepatitis in patients treated with medication with a narrow therapeutic window and sensitive to mild metabolic impairment of the liver.
Forsigtighed tilrådes derfor, når PegIntron behandling mod kronisk hepatitis initieres hos patienter der behandles med lægemidler med et snævert terapeutisk vindue og følsomhed for mild metabolisk svækkelse af leveren.

Please refer to the respective Summary of Product Characteristics of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with Peg Intron and ribavirin.
For de antiretrovirale lægemidler, der skal tages samtidig med HCV- behandling, henvises der til disses respektive produktresuméer for kendskab og håndtering af toksicitet, der er specifik for det enkelte produkt samt potentialet for overlappende toksiciteter med PegIntron og ribavirin.

Please refer to the respective Summary of Product Characteristics of the antiretroviral medicinal products that are to be taken concurrently with HCV therapy for awareness and management of toxicities specific for each product and the potential for overlapping toxicities with Peg Intron in combination with ribavirin.
For de antiretrovirale lægemidler, der skal tages samtidig med HCV- behandling, henvises der til disses respektive produktresuméer for kendskab og håndtering af toksicitet, der er specifik for det enkelte produkt samt potentialet for overlappende toksiciteter med PegIntron i kombination med ribavirin.